This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
References
Horny HP . Mastocytosis: an unusual clonal disorder of bone marrow-derived hematopoietic progenitor cells. Am J Clin Pathol 2009; 132: 438–447.
Agis H, Sotlar K, Valent P, Horny HP . Ph-Chromosome-positive chronic myeloid leukemia with associated bone marrow mastocytosis. Leuk Res 2005; 29: 1227–1232.
Horny HP, Sotlar K, Stellmacher F, Krokowski M, Agis H, Schwartz LB et al. The tryptase positive compact round cell infiltrate of the bone marrow (TROCI-BM): a novel histopathological finding requiring the application of lineage specific markers. J Clin Pathol 2006; 59: 298–302.
Hussein K, Bock O, Theophile K, Seegers A, Arps H, Basten O et al. Chronic myeloproliferative diseases with concurrent BCR-ABL junction and JAK2V617F mutation. Leukemia 2008; 22: 1059–1062.
Buesche G, Ganser A, Schlegelberger B, von Neuhoff N, Gadzicki D, Hecker H et al. Marrow fibrosis and its relevance during imatinib treatment of chronic myeloid leukemia. Leukemia 2007; 21: 2420–2427.
Sotlar K, Bache A, Stellmacher F, Bültmann B, Valent P, Horny HP . Systemic mastocytosis associated with chronic idiopathic myelofibrosis: a distinct subtype of systemic mastocytosis associated with a clonal hematological non-mast cell lineage disorder carrying the activating point mutations KITD816V and JAK2V617F. J Mol Diagn 2008; 10: 58–66.
Michor F . Mathematical models of cancer stem cells. J Clin Oncol 2008; 26: 2854–2861.
Abruzzese E, Gozzetti A, Galimberti S, Trawinska MM, Caravita T, Siniscalchi A et al. Characterization of Ph-negative abnormal clones emerging during imatinib therapy. Cancer 2007; 109: 2466–2472.
Acknowledgements
We wish to thank Sabine Schröter, Nadine Preiß and Markus Meyer for their skillful work in the laboratory. Furthermore, we are grateful to Dr Philipp Ahrens for his sophisticated assistance of FFPE–FISH evaluation. Research grants: José Carreras Leukämie-Stiftung SP10/06 (KH).
Author contribution
Histopathology (KH, H-PH, GB, HK), molecular pathology (KH, OB), cytogenetic analysis (GG), FFPE-FISH (KH, GG), clinical data (MG), study design and manuscript preparation (KH, H-PH, GB, MG, GG, HK, OB).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no conflict of interest.
Additional information
Supplementary Information accompanies the paper on the Leukemia website
Supplementary information
Rights and permissions
About this article
Cite this article
Hussein, K., Horny, HP., Büsche, G. et al. Systemic mastocytosis (SM) with associated BCR-ABL-positive myelogenous leukaemia (SM-AHNMD): evidence that mast cells do not belong to the leukaemic clone. Leukemia 25, 1050–1053 (2011). https://doi.org/10.1038/leu.2011.41
Published:
Issue Date:
DOI: https://doi.org/10.1038/leu.2011.41